Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 11, Issue 8, Pages 1131-1147
Publisher
Informa Healthcare
Online
2014-05-08
DOI
10.1517/17425247.2014.912211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sintering of Catalytic Nanoparticles: Particle Migration or Ostwald Ripening?
- (2013) Thomas W. Hansen et al. ACCOUNTS OF CHEMICAL RESEARCH
- Liposomes for brain delivery
- (2013) Francesco Lai et al. Expert Opinion on Drug Delivery
- In Vitro and in Vivo Evaluation of Lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain Delivery
- (2013) Feng-Yun Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanistic Insights of Curcumin Interactions with the Core-Recognition Motif of β-Amyloid Peptide
- (2013) Priyadharshini Kumaraswamy et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- The Alzheimer's Amyloid-β(1–42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization
- (2013) William M. Tay et al. JOURNAL OF MOLECULAR BIOLOGY
- Hierarchical self-assembly of Tjernberg peptide at nanoscale
- (2013) Priyadharshini Kumaraswamy et al. Soft Matter
- Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease
- (2012) Fei Li et al. CURRENT PHARMACEUTICAL DESIGN
- Preparation, characterization,in vivoand biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model
- (2012) Mohammad Yusuf et al. JOURNAL OF DRUG TARGETING
- Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease
- (2012) Anila Mathew et al. PLoS One
- The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue
- (2011) Mara Canovi et al. BIOMATERIALS
- New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations
- (2011) N. Başaran Mutlu et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Experimental Therapeutic Effects of Hybrid Liposomes on the Alzheimer's Disease in Vitro
- (2011) Keiko ZAKO et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing
- (2010) Gunter P. Eckert et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
- (2010) Marco Gobbi et al. BIOMATERIALS
- Drug development for Alzheimer's disease: Where are we now and where are we headed?
- (2009) Marwan N. Sabbagh American Journal Geriatric Pharmacotherapy
- Recent developments in Alzheimer's disease therapeutics
- (2009) Michael S Rafii et al. BMC Medicine
- Curcumin blocks brain tumor formation
- (2009) Sudarshana Purkayastha et al. BRAIN RESEARCH
- Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes
- (2009) Soraya L. Valles et al. BRAIN RESEARCH
- Effective Stabilization of Curcumin by Association to Plasma Proteins: Human Serum Albumin and Fibrinogen
- (2009) Mandy H. M. Leung et al. LANGMUIR
- A study of rivastigmine liposomes for delivery into the brain through intranasal route
- (2008) Karthik Arumugam et al. ACTA PHARMACEUTICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now